Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Mercy Children's Hospital
mi
from
Toledo, OH
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Mercy Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Oregon Health and Science University
mi
from
Portland, OR
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Penn State Hershey Children's Hospital
mi
from
Hershey, PA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Penn State Hershey Children's Hospital
mi
from
Hershey, PA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Saint Christopher's Hospital for Children
mi
from
Philadelphia, PA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Saint Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Palmetto Health Richland
mi
from
Columbia, SC
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Palmetto Health Richland
mi
from
Columbia, SC
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
T C Thompson Children's Hospital
mi
from
Chattanooga, TN
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
T C Thompson Children's Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Texas Tech University Health Science Center-Amarillo
mi
from
Amarillo, TX
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Texas Tech University Health Science Center-Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Baylor College of Medicine
mi
from
Houston, TX
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Scott & White Memorial Hospital
mi
from
Temple, TX
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
University of Vermont
mi
from
Burlington, VT
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Carilion Clinic Children's Hospital
mi
from
Roanoke, VA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Carilion Clinic Children's Hospital
mi
from
Roanoke, VA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
West Virginia University Charleston
mi
from
Charleston, WV
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
West Virginia University Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Marshfield Clinic
mi
from
Marshfield, WI
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated:  12/7/2017
The Children's Hospital at Westmead
mi
from
Sydney,
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors
Status: Enrolling
Updated: 12/7/2017
The Children's Hospital at Westmead
mi
from
Sydney,
Click here to add this to my saved trials
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases
Status: Enrolling
Updated:  12/7/2017
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases
Status: Enrolling
Updated: 12/7/2017
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Status: Enrolling
Updated:  12/7/2017
OHSU Knight Cancer Institute
mi
from
Portland, OR
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Status: Enrolling
Updated: 12/7/2017
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Status: Enrolling
Updated:  12/7/2017
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Status: Enrolling
Updated: 12/7/2017
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Status: Enrolling
Updated:  12/7/2017
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
Status: Enrolling
Updated: 12/7/2017
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Phase II Trial of Cetuximab and Dasatinib in Patients With Cetuximab-resistant, Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck and Low Serum IL-6
Status: Enrolling
Updated:  12/7/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Phase II Trial of Cetuximab and Dasatinib in Patients With Cetuximab-resistant, Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck and Low Serum IL-6
Status: Enrolling
Updated: 12/7/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Goodyear, AZ
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Anaheim, CA
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Long Beach, CA
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Farmington, CT
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Farmington, CT
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Alexandria, LA
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Brewer, ME
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Brewer, ME
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Westminster, MD
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Westminster, MD
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Fairhaven, MA
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Fairhaven, MA
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Detroit, MI
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
East Setauket, NY
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
East Setauket, NY
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Durham, NC
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Hickory, NC
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Bismarck, ND
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Bismarck, ND
Click here to add this to my saved trials
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/7/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
A Randomized, Double-blind, Multi-center Phase 2 Trial of Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/7/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials